China has emerged as the global leader in new drug approvals, surpassing both the United States and the European Union in 2025. The country’s regulatory agencies have authorized a record number of innovative treatments, including groundbreaking cancer therapies, rare disease drugs, and advanced vaccines. Officials attribute this surge to accelerated approval processes, increased investment in […]